Bone densitometry firm Hologic of Waltham, MA, said thatdemandfor its Acclaim fanbeam bone measurement devices contributed toa doubling of revenue and a sharp spike in net income in its secondquarter (end-March). Hologic posted revenues of $18.8
Bone densitometry firm Hologic of Waltham, MA, said thatdemandfor its Acclaim fanbeam bone measurement devices contributed toa doubling of revenue and a sharp spike in net income in its secondquarter (end-March).
Hologic posted revenues of $18.8 million for the quarter, comparedwith $9 million in the second quarter of 1995. Net income forthe most recent period stood at $3 million, compared with netincome of $154,000 in the same period last year. Hologic has alsoamassed a war chest of $57.9 million in cash and cash equivalents,compared with $7.4 million in cash last year.
The news sent Hologic's stock up $2 a share to close at $32.50on May 2. Shares of bone densitometry rival Lunar fell sharply,losing $3.50 a share to close at $36.50.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.